摘要:
The present invention relates to novel biologically active tricyclic compounds of the general formula: and salts thereof having potent anti-obesity properties.
摘要:
Compounds of formula I and pharmaceutically acceptable salts thereof; in which R, and R 2 , which are the same or different, are H or an optionally substituted hydrocarbon group or R, and R 2 together with the nitrogen atom to which they are attached form an optionally substituted heterocyclic ring;
R 3 is an optionally substituted aromatic hydrocarbon group; and R 4 is a hydrocarbon group containing at least one substituent selected from the group consisting of hydroxy and acylated derivatives thereof, optionally substituted alkoxy groups, optionally substituted cycloalkyloxy groups, optionally substituted alkylenedioxy groups, oxo and groups of formula S(O) p R 5 in which p is 0, 1 or 2 and R 5 is an alkyl group, said hydrocarbon group being optionally substituted by additional substituents, are useful in the treatment of depression.
摘要:
10,11-Dihydro-5H-dibenzo[a,d]cycloheptadien-Derivate der Formel 1 worin
R 1 ein Wasserstoffatom oder eine C 1-6 -Alkyl-, C 2-6 -Alkenyl-, C 2-6 -Alkinyl, C 1-6 -Hydroxyalkyl- oder C 1-4 -Alkoxy-C 1- 4 -alkylgruppe und R2 ein Wasserstoffatom oder R1 und R2 zusammen mit dem sie verbindenden Stickstoffatom einen Morpholinring oder einen Piperidinring, der in der 4-Stellung durch eine Hydroxygruppe und oder durch eine gegebenenfalls durch ein Halogenatom substituierte Phenylgruppe substituert sein kann, bedeuten, sowie deren Salze mit physiologisch verträglichen Säuren. Ihre Herstellung wird beschrieben. Sie sind zur Therapie von Herzrhythmusstörungen geeignet.
摘要:
New compounds, useful for the treatment of hyperten- sion, have the formula and pharmaceutically acceptable salts thereof, wherein
R, is hydrogen or methyl; R 2 is hydrogen, alkyl, alkanoyl, or arylcarbonyl; R 3 and R 4 are each aryl; R 3 and R 4 are each cycloalkyl; R 3 is hydrogen or alkyl and R 4 is cycloalkyl or 9H-fluoren-9-yl; or R 3 is hydrogen or alkyl and R 4 is heteroaryl; R 5 and R 6 are the same or different and each is hydrogen, hydroxy, alkoxy or alkanoyl; and n is 1, 2, 3 and 4.
摘要:
Novel phenethylamine derivatives are central nervous system antidepressants. The compounds are those having the formula where A is where the dotted line represents optional unsaturation; R 1 and R 7 are, independently, hydrogen or C 1 -C 6 alkyl; R 2 is C 1 -C 6 alkyl; R 4 is hydrogen, C 1 -C 4 alkyl, formyl or C 2 -C 7 alkanoly; R 5 and R 6 are hydrogen or defined substituents and n is 0,1,2,3, or 4 and their pharmaceutically acceptable salts. Novel intermediates for the preparation of these compounds include those of the formulae